Emerging biological roles for erythropoietin in the nervous system
The DOI matches its Crossref record; 107 of the 108 references it cites were found in a registry or an index.
Abstract
Erythropoietin mediates an evolutionarily conserved, ancient immune response that limits damage to the heart, the nervous system and other tissues following injury. New evidence indicates that erythropoietin specifically prevents the destruction of viable tissue surrounding the site of an injury by signalling through a non-haematopoietic receptor. Engineered derivatives of erythropoietin that have a high affinity for this receptor have been developed, and these show robust tissue-protective effects in diverse preclinical models without stimulating erythropoiesis. A recent successful proof-of-concept clinical trial that used erythropoietin to treat human patients who had suffered a stroke encourages the evaluation of both this cytokine and non-erythropoietic derivatives as therapeutic agents to limit tissue injury.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Erythropoietin was originally recognized via its role in erythropoiesis [2145-2147] (hence its name, of course), but it has become evident that it has many other roles, and in particular it is observed phenomenologically that erythropoietin (and non-erthyropoetic derivatives) is protective in a number of inflammatory conditions that accompany many diseases such as those listed above [940,942,2148-”
From Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases (2009) · cites this paper as [2150]
Citations
Cites
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
Brines, M. L., Ghezzi, P., Keenan, S., Agnello, D., de Lanerolle, N. C., Cerami, C., Itri, L. M., & Cerami, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.19.10526 · Cited by 1,402 · cited 1×
“Follow-up studies confirmed erythropoietin to be a neuroprotective factor in hypoxic-ischaemic, traumatic, excitotoxic and inflammatory injurie”
BackgroundSelf-citationHIF-1 and mechanisms of hypoxia sensing
Semenza, G. L. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00194-0 · Cited by 1,268
Henke, M., Laszig, R., Rübe, C., Schäfer, U., Haase, K.-D., Schilcher, B., Mose, S., Beer, K. T., Burger, U., Dougherty, C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14567-9 · Cited by 1,250 · cited 1×
“It is worrying that some cancer patients treated with rhEPO have also shown tumour expansio”
BackgroundErythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
Ehrenreich, H., Hasselblatt, M., Dembowski, C., Cepek, L., Lewczuk, P., Stiefel, M., Rustenbeck, H.-H., Breiter, N., Jacob, S., Knerlich, F., et al. (2002) · Molecular Medicine · doi:10.1007/bf03402029 · Cited by 1,028
Self-citationJuhaszova, M., Zorov, D. B., Kim, S.-H., Pepe, S., Fu, Q., Fishbein, K. W., Ziman, B. D., Wang, S., Ytrehus, K., Antos, C. L., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19906 · Cited by 1,026
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
Sirén, A.-L., Fratelli, M., Brines, M., Goemans, C., Casagrande, S., Lewczuk, P., Keenan, S., Gleiter, C., Pasquali, C., Capobianco, A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051606598 · Cited by 1,019
Self-citationIn vivo evidence that erythropoietin protects neurons from ischemic damage
Sakanaka, M., Wen, T.-C., Matsuda, S., Masuda, S., Morishita, E., Nagao, M., & Sasaki, R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4635 · Cited by 949 · cited 1×
“Follow-up studies confirmed erythropoietin to be a neuroprotective factor in hypoxic-ischaemic, traumatic, excitotoxic and inflammatory injurie”
BackgroundDigicaylioglu, M., & Lipton, S. A. (2001) · Nature · doi:10.1038/35088074 · Cited by 923 · cited 1×
“Furthermore, although it has been reported that STAT is part of erythropoietin's neuroprotective signalling cascade in vitro , in vivo studies largely have not supported the involvement of STATs in erythropoietin cytoprotectio”
BackgroundPurification of human erythropoietin.
Miyake, T., Kung, C. K., & Goldwasser, E. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)63387-9 · Cited by 886
Derivatives of Erythropoietin That Are Tissue Protective But Not Erythropoietic
Leist, M., Ghezzi, P., Grasso, G., Bianchi, R., Villa, P., Fratelli, M., Savino, C., Bianchi, M., Nielsen, J., Gerwien, J., et al. (2004) · Science · doi:10.1126/science.1098313 · Cited by 803
Self-citation
Cited by
Items 501–527 of 527
Singh, M., Zhao, Y., Gastaldi, V. D., Wojcik, S. M., Curto, Y., Kawaguchi, R., Merino, R. M., Garcia-Agudo, L. F., Taschenberger, H., Brose, N., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.02.04.527116
Neuroprotection induced by erythropoietin
Maltaneri, R. E., Chamorro, M. E., Nesse, A. B., & Vittori, D. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23763-8.00059-2
Kwon, O.-H., Bae, J., Byun, J. C., Jeong, H.-J., Liu, J., Lee, C., Yoo, S., Lee, S., & Moon, C. (2025) · Research Square · doi:10.21203/rs.3.rs-5779616/v1
Mahdy, H. M. (2025) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273367111250307081826
KILLMAR, J. T., Xue, Y., Wang, R., Rex, T. S., Khan, M. M., Liao, F., & McDonald, M. P. (2025) · Research Square · doi:10.21203/rs.3.rs-6465973/v1 · Cited by 1
Ketamine for neuropathic pain: Animal and human studies
Dahan, A., Niesters, M., Sarton, E. Y., & van Velzen, M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29930-8.00016-3
Phan, V. H. G., Duong, H.-S., Le, Q.-G. T., Janarthanan, G., Vijayavenkataraman, S., Nguyen, H.-N. H., Nguyen, B.-P. T., Manivasagan, P., Jang, E., Li, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26635158
Offen, N., Flemming, J., Kamawal, H., Ahmad, R., Wolber, W., Geis, C., Zaehres, H., Schöler, H. R., Ehrenreich, H., Müller, A. M., et al. (2013) · Figshare · doi:10.6084/m9.figshare.7194182
Alam, J. (2025) · Digital Commons - University of South Florida (University of South Florida)
Hartung, T., Freyer, D., Zemella, A., Radbruch, H., Weiner, J. M., El-Din, J. J., Meisel, A., & Priller, J. (2026) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1677505
Babazadeh, M., Sanaie, S., & Rahnemayan, S. (2026) · BMC Neurology · doi:10.1186/s12883-026-04627-9 · Cited by 1
“Specifically, preclinical investigations suggest that EPO and its derivatives may counteract key pathophysiological features of neurodegeneration, including oxidative stress, mitochondrial dysfunction, excitotoxicity, and neuroinflammation [7–13].”
Nolan, J., Johansyah, T. K. P., Krisnawan, G. A. E., & Mahadewa, T. G. B. (2026) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-026-01095-3
Neuroprotection and Cerebral Malaria, Of Mice and Men
Bienvenu, A. (2009) · theses.fr (ABES) · doi:10.70675/a76be862z7bbcz42ecz8f02za2ab9417a6cd
Progeniteurs endotheliaux : étude des mécanismes de recrutement en situation physiopathologique.
Hubert, L. (2012) · theses.fr (ABES) · doi:10.70675/a9c980dczf4caz44bbz9b8ez15a141f9afc1
Innervation cutanée et neuropathies périphériques
Danigo, A. (2014) · theses.fr (ABES) · doi:10.70675/e90b41a4z0179z4eaazb3d5z66ed50b8fc9c
Perrin‐Terrin, A. (2018) · theses.fr (ABES) · doi:10.70675/e19e922bz4ab1z4df2z8e00z839db7c46630
From Erythropoiesis to Circuit Rewiring: Erythropoietin as a Precision Tool for Neurorestoration
Almaguer‐Melian, W., Mercerón‐Martínez, D., Acosta, B. B., & Bergado, J. A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27104329
“…EPO has actions beyond erythropoiesis [29], neurons possess functional EPO receptors [32], and the hormone can cross the blood-brain barrier [33], a highly selective semi-permeable border of endothelial cells that prevents most substances in the blood from entering the brain, which is a…”
Erythropoietin impacts immune adaptation through myeloid-cell programming
Zhang, X., & Engleman, E. G. (2026) · Trends in Immunology · doi:10.1016/j.it.2026.08.014
Byun, J. H., Park, I., Yun, H., & Kim, J. K. (2026) · Computational and Structural Biotechnology Journal · doi:10.34133/csbj.0248
Erythropoietin beyond red blood cells: Systemic and oncological functions (Review)
Danková, K., Solárová, Z., Harvanik, P., Šemeláková, M., & Solár, P. (2026) · Molecular Medicine Reports · doi:10.3892/mmr.2026.14050
Exercise-induced Hypoxia, Angiogenesis, and Behavioral Flexibility in the Adult Rat
Berggren, K. L. (2013) · UWM Digital Commons (University of Wisconsin–Milwaukee) · Cited by 1
Aust, S. C. (2008) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-268
Metadata
- Authors
- Brines, M., & Cerami, A.
- Corresponding author
- Brines, Michael
- Venue
- Nature Reviews Neuroscience
- Published
- 2005-06-01
- Volume
- 6
- Issue
- 6
- Pages
- 484-494
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W2168867226
- Cited by
- 523
- References
- 108
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 6 · 2023: 8 · 2022: 18 · 2021: 21 · 2020: 13 · 2019: 25 · 2018: 17 · 2017: 16 · 2016: 21 · 2015: 19 · 2014: 22 · 2013: 30 · 2012: 38
- FWCI
- 6.14
- Type
- journal article
- Language
- en
- Update notices
- correction (2005-08-01)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- www.springer.com/tdm (unspecified)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heme Oxygenase-1 and Carbon Monoxide
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Keywords
- erythropoietin, nervous system, neuroprotection, tissue damage, stroke, neuroinflammation
- MeSH terms
- Animals, Central Nervous System, Erythropoietin, Humans, Signal Transduction, Receptors, Cytokine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.